Clinical Trial Update: Effect of SGLT2i on Cardiovascular Biomarkers in Patients With Type 2 Diabetes and CKD Stage 3b-4

View source ↗

Summary

A completed study evaluating the effect of an SGLT2 inhibitor on cardiovascular biomarkers in patients with type 2 diabetes mellitus and chronic kidney disease …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitor

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Kidney Disease, Chronic, Diabetes | Status: COMPLETED